These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13564256)

  • 1. Diffuse traumatic degeneration of the cerebral gray matter.
    DENST J; RICHEY TW; NEUBUERGER KT
    J Neuropathol Exp Neurol; 1958 Jul; 17(3):450-60. PubMed ID: 13564256
    [No Abstract]   [Full Text] [Related]  

  • 2. PROGRESSIVE POLIODYSTROPHY. THE DEGENERATIONS OF CEREBRAL GRAY MATTER.
    DREIFUSS FE; NETSKY MG
    Am J Dis Child; 1964 Jun; 107():649-56. PubMed ID: 14133827
    [No Abstract]   [Full Text] [Related]  

  • 3. Late juvenile degeneration of cerebral grey matter.
    SMULDERS FJ
    Folia Psychiatr Neurol Neurochir Neerl; 1956 Jun; 59(3):223-9. PubMed ID: 13365726
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the effect of monovalent chloride compounds on the nerve cells of the central gray matter of the cerebral cortex. (Preliminary report)].
    RUSCAKOVA D
    Biologia (Bratisl); 1961; 16():925-9. PubMed ID: 14495337
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterotopic cerebral gray matter as an epileptogenic focus.
    LAYTON DD
    J Neuropathol Exp Neurol; 1962 Apr; 21():244-9. PubMed ID: 14463062
    [No Abstract]   [Full Text] [Related]  

  • 6. Widespread softening of the cerebral gray matter in infancy. Its probable etiology in a paranatal circulatory disorder.
    COURVILLE CB
    Bull Los Angel Neuro Soc; 1960 Jun; 25():72-88. PubMed ID: 13812423
    [No Abstract]   [Full Text] [Related]  

  • 7. Case studies in cerebral anoxia. IV. Charac teristic changes in cerebral gray matter in anterior poliomyelitis.
    COURVILLE CB; BLOSSOM RA
    Bull Los Angel Neuro Soc; 1954 Sep; 19(3):151-9. PubMed ID: 13199451
    [No Abstract]   [Full Text] [Related]  

  • 8. Case studies in cerebral anoxia. VI. Typical anoxic alterations in the cerebral gray matter after overdosage of barbiturates.
    COURVILLE CB
    Bull Los Angel Neuro Soc; 1955 Mar; 20(1):16-24. PubMed ID: 14364016
    [No Abstract]   [Full Text] [Related]  

  • 9. Early Childhood Depression and Alterations in the Trajectory of Gray Matter Maturation in Middle Childhood and Early Adolescence.
    Luby JL; Belden AC; Jackson JJ; Lessov-Schlaggar CN; Harms MP; Tillman R; Botteron K; Whalen D; Barch DM
    JAMA Psychiatry; 2016 Jan; 73(1):31-8. PubMed ID: 26676835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the cerebral gray matter volume in response to fingolimod therapy in multiple sclerosis: A more analytic view.
    McGee JC; Minagar A
    J Neurol Sci; 2017 Dec; 383():230-231. PubMed ID: 29102163
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on allergic encephalitis experimentally produced by the use of gray matter phosphatide.
    SAWAMI H
    Folia Psychiatr Neurol Jpn; 1952 Sep; 6(2):138-54. PubMed ID: 13060420
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochemistry of cerebral grey matter.
    DIXON KC
    Q J Exp Physiol Cogn Med Sci; 1954; 39(3):129-51. PubMed ID: 13194837
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral gray matter changes in persistent postural perceptual dizziness.
    Wurthmann S; Naegel S; Schulte Steinberg B; Theysohn N; Diener HC; Kleinschnitz C; Obermann M; Holle D
    J Psychosom Res; 2017 Dec; 103():95-101. PubMed ID: 29167054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic cortical gray matter volume changes after botulinum toxin in cervical dystonia.
    Delnooz CC; Pasman JW; van de Warrenburg BP
    Neurobiol Dis; 2015 Jan; 73():327-33. PubMed ID: 25447226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the experimental encephalitis produced with the use of gray matter phosphatide and vaccinelymph.
    KAWAI H
    Folia Psychiatr Neurol Jpn; 1954 Dec; 8(3):281-93. PubMed ID: 14365945
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative assessment of cerebral gray matter density change in progressive supranuclear palsy using voxel based morphometry analysis and cerebral MR T1-weighted FLAIR imaging.
    Wang G; Wang J; Zhan J; Nie B; Li P; Fan L; Zhu H; Feng T; Shan B
    J Neurol Sci; 2015 Dec; 359(1-2):367-72. PubMed ID: 26671144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent decreases of high energy phosphates in cerebral gray matter of patients with bipolar I disorder: a preliminary phosphorus-31 magnetic resonance spectroscopic imaging study.
    Dudley JA; Lee JH; Durling M; Strakowski SM; Eliassen JC
    J Affect Disord; 2015 Apr; 175():251-5. PubMed ID: 25658500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on allergic encephalitis experimentally produced by the use of gray matter phosphatide and egg albumin.
    KAWAI H
    Folia Psychiatr Neurol Jpn; 1954 Dec; 8(3):265-80. PubMed ID: 14365944
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kety's & Schmidt's method of determination of cerebral circulation in recent & old intracranial injuries].
    LENNARTZ H
    Dtsch Z Nervenheilkd; 1958; 177(6):563-76. PubMed ID: 13547873
    [No Abstract]   [Full Text] [Related]  

  • 20. The colour of the grey matter of the brain.
    CLELAND JB
    Med J Aust; 1947 Aug; 2(5):138. PubMed ID: 20259897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.